We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.56B
AUM Growth
+$200M
Cap. Flow
-$12.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
35.03%
Holding
185
New
38
Increased
44
Reduced
32
Closed
58

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$34.8M
2
AGN.PRA
Allergan plc
AGN.PRA
+$31.9M
3
EBAY icon
eBay
EBAY
+$28.5M
4
YUM icon
Yum! Brands
YUM
+$27.1M
5
HES
Hess
HES
+$22.8M

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$29.6M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$23M
3
SNV
Synovus
SNV
+$21.7M
4
BLMN icon
Bloomin' Brands
BLMN
+$21.2M
5
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Consumer Discretionary 10.07%
3 Technology 9.69%
4 Consumer Staples 5.72%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MHK icon
151
Mohawk Industries
MHK
$7.5B
– –
-81,150
Closed -$15.1M
MNST icon
152
Monster Beverage
MNST
$94.3B
– –
-171,000
Closed -$3.94M
NVDA icon
153
PUT
NVIDIA
NVDA
$4.86T
– –
-4,140,000
Closed -$2.17M
SNV
154
DELISTED
Synovus
SNV
– –
-773,516
Closed -$21.7M
STLA icon
155
Stellantis
STLA
$21.7B
– –
-613,484
Closed -$6.52M
TEVA icon
156
Teva Pharmaceuticals
TEVA
$40.8B
– –
-40,000
Closed -$2.49M
UAL icon
157
United Airlines
UAL
$39.4B
– –
-130,000
Closed -$8.74M
VNDA icon
158
CALL
Vanda Pharmaceuticals
VNDA
$307M
– –
-1,400,000
Closed -$13M
WSM icon
159
Williams-Sonoma
WSM
$26.9B
– –
-70,000
Closed -$2.79M
XBI icon
160
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-225,000
Closed -$16.9M
SUM
161
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
– –
-211,853
Closed -$4.43M
DOOR
162
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
– –
-114,500
Closed -$7.7M
ICD
163
DELISTED
Independence Contract Drilling, Inc.
ICD
– –
-36,125
Closed -$5.04M
KIN
164
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-348,753
Closed -$2.49M
CLGX
165
DELISTED
Corelogic, Inc.
CLGX
– –
-230,273
Closed -$8.12M
AMAG
166
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-209,017
Closed -$11.4M
ACHN
167
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-291,000
Closed -$2.87M
LXFT
168
DELISTED
Luxoft Holding, Inc.
LXFT
– –
-156,831
Closed -$8.11M
IDTI
169
DELISTED
Integrated Device Technology I
IDTI
– –
-385,000
Closed -$7.71M
PF
170
DELISTED
Pinnacle Foods, Inc.
PF
– –
-24,919
Closed -$1.02M
CAA
171
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-100,000
Closed -$4.5M
TLOG
172
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
– –
-263,827
Closed -$1.16M
RAX
173
DELISTED
Rackspace Hosting Inc
RAX
– –
-250,000
Closed -$12.9M
MRD
174
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
– –
-100,000
Closed -$1.77M
BRCM
175
DELISTED
BROADCOM CORP CL-A
BRCM
– –
-531,869
Closed -$23M
4 5 6
7
8

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Kingdon Capital Management held 185 positions worth $2.56B, up 8.5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kingdon Capital Management's Q2 2015 filing shows 38 new, 44 increased, 32 reduced and 58 closed positions. Its largest new stake was Allergan plc: 30,500 shares worth $31.9M. The largest sale was ANACOR PHARMACEUTICALS INC COM, an estimated $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kingdon Capital Management's largest Q2 2015 buy was Allergan plc: 30,500 shares worth $31.9M.
  • Kingdon Capital Management added most to Adobe in Q2 2015, an estimated $34.8M increase.
  • Kingdon Capital Management's biggest Q2 2015 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $29.6M.
  • Kingdon Capital Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $23M.
  • Kingdon Capital Management's ten largest holdings make up 35% of its $2.56B portfolio in Q2 2015.
  • Kingdon Capital Management opened 38 new positions and closed 58 in Q2 2015.
  • Kingdon Capital Management's portfolio value rose 8.5% quarter-over-quarter to $2.56B.

Based on Kingdon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.